Recent research found strain parameters taken from a cine MRI-based deformable registration algorithm (DRA) can determine the severity of amyloid buildup in the heart and may provide prognostic information on patients with light-chain (AL) amyloidosis.

New research from Michigan Technological University suggests an hour of mindfulness meditation can reduce anxiety and positively impact cardiovascular health—in particular, blood pressure. Study findings were presented April 23 at the 2018 Experimental Biology Meeting in San Diego.

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy company using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced first patient enrollment into the pivotal U.S. REFRESH 2-AKI trial.

Metabolically healthy obesity (MHO) is not a stable state—rather, it's a slippery slope toward metabolic syndrome and increased risk of cardiovascular disease (CVD), suggests a long-term study published April 23 in the Journal of the American College of Cardiology.

Researchers have identified what they believe is a molecular explanation for why cardiovascular disease (CVD) occurs later in women than in men.

Intravenous nicorandil cut the risk of periprocedural myocardial injury (pMI) after percutaneous coronary intervention (PCI) by 49 percent among patients 65 and older, according to a substudy of a randomized trial published in PLOS One.

Medtronic’s IN.PACT Admiral drug-coated balloon (DCB) has received an expanded indication from the FDA and is now cleared to treat long superficial femoral artery lesions up to 360 millimeters, the company announced April 23.

About 47 percent of on-duty firefighter deaths are heart-related, according to the U.S. Fire Administration (USFA).